Scott L. Burrows, Chief Financial Officer at Arcutis Biotherapeutics, Inc. (ARQT), sold 303 shares at $16.86 ($5K) on 2022-03-04, disclosed to the SEC on 2022-03-07.
Scheduled sale ($5k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.86 | 293 | $5K | 96.8% |
| 2 | $16.44 | 10 | $164 | 3.2% |
| Total | $16.85 avg | 303 | $5K | 100% |
| Filing → |
| SYRE | SELL | 2026-08-05 | $717K | — | Filing → |
| SYRE | SELL | 2026-07-02 | $658K | — | Filing → |
| SYRE | SELL | 2026-06-26 | $1.3M | — | Filing → |